Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Quinpirole is a psychoactive drug and research chemical that acts as a potent, selective agonist of dopamine D2 and D3 receptors. It is primarily used in scientific and laboratory research, particularly in models studying dopaminergic signaling, movement, compulsive behaviors, and neuroprotection. Quinpirole exhibits high affinity for the dopamine D2 receptor (Ki ≈ 4.8 nM) and moderate affinity for D3 (Ki ≈ 24 nM); it displays much lower activity at D4 and negligible activity at D1 receptors. Mechanistically, it activates dopamine D2-like receptors, reducing neuronal excitability and modulating neurotransmitter release. Quinpirole is commonly used to induce or modulate behaviors in animal models relevant to obsessive-compulsive disorder, addiction, Parkinson's disease, and sleep regulation. It is not used therapeutically in humans.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on quinpirole.